Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Abbott Laboratories completes Piramel unit buyout
Yahoo/AP
Wednesday, September 8, 2010 - 11:05am
tags:
M&A, Abbott Laboratories, Piramal Healthcare, India
Onyx Sells Japan Rights to Blood Cancer Drug
TheStreet.com
Wednesday, September 8, 2010 - 7:36am
tags:
ONYX Pharmaceuticals, Japan, Ono, Carfilzomib
Gilead: Is This Cash Machine Running on Empty?
Motley Fool
Wednesday, September 8, 2010 - 7:23am
tags:
Gilead Sciences
Sanofi's CEO Viehbacher Pitches Genzyme Investors on Bid
Bloomberg
Wednesday, September 8, 2010 - 6:29am
tags:
Pharma CEOs, Chris Viehbacher, M&A, Genzyme, Sanofi
Forest Labs says panel supports its antibiotic
Yahoo/AP
Wednesday, September 8, 2010 - 6:27am
tags:
Forest Labs, advisory panels, antibiotics, FDA, ceftaroline
Bristol-Myers Agrees to Acquire ZymoGenetics for $885 Million
NY Times, NY
Tuesday, September 7, 2010 - 9:29pm
tags:
Bristol-Myers Squibb, M&A, ZymoGenetics
Merck schizophrenia drug approved for 2 new uses
Yahoo/AP
Tuesday, September 7, 2010 - 5:04pm
tags:
Merck, schizophrenia, FDA, Saphris, mania, bipolar disorder
Teva Wins Copaxone Protection
Forbes
Tuesday, September 7, 2010 - 5:03pm
tags:
Teva Pharmaceuticals, Copaxone, MS, multiple sclerosis, patents, Novartis, Momenta
Vertex Cures Hard-to-Treat Hep C Patients
TheStreet.com
Tuesday, September 7, 2010 - 5:01pm
tags:
Vertex Pharmaceuticals, hepatitis C, Telaprevir
Allergan Directors Are Sued Over Marketing of Botox
Bloomberg
Tuesday, September 7, 2010 - 2:02pm
tags:
Botox, Allergan, lawsuits, off-label
'Multiple Shrinkage' Weighs on Large-Cap Biotech
TheStreet.com
Tuesday, September 7, 2010 - 1:12pm
tags:
biotech, Amgen, Celgene, Biogen Idec, Gilead Sciences, Genzyme
Astra boosts emerging markets with Aurobindo deal
Reuters
Tuesday, September 7, 2010 - 12:41pm
tags:
emerging markets, India, AstraZeneca, Aurobindo
J&J Wants Remicade Damages From Merck
Pharmalot
Tuesday, September 7, 2010 - 12:39pm
tags:
Remicade, Merck, JNJ
Biovail-Valeant combo will cost 25% of all jobs
Fierce Biotech
Tuesday, September 7, 2010 - 12:38pm
tags:
Biovail, Valeant Pharmaceuticals, layoffs, M&A
Roche Layoffs: Whose Jobs Are Safe, and Whose Aren’t?
BNET Pharma
Tuesday, September 7, 2010 - 12:12pm
tags:
Roche, Genentech, layoffs
Idenix shares crushed; drug sector indexes slide
Marketwatch
Tuesday, September 7, 2010 - 12:11pm
tags:
Idenix, drug stocks
Big Pharma Headed for More Deals, Less New Drug Applications
Seeking Alpha
Tuesday, September 7, 2010 - 12:09pm
tags:
Big Pharma, M&A, Pfizer, Merck, Novartis, GSK, Genzyme, Celgene, AstraZeneca, Abbott Laboratories, FoldRx
Sanofi hints at higher Genzyme bid as GSK remains on the sidelines
Fierce Biotech
Tuesday, September 7, 2010 - 12:04pm
tags:
GSK, M&A, Sanofi, Genzyme
Glaxo slides on Avandia woes in U.K.
Marketwatch
Tuesday, September 7, 2010 - 12:03pm
tags:
GSK, Avandia, diabetes, UK
Somaxon Pharmaceuticals Announces Commercial Availability of Silenor
Yahoo
Tuesday, September 7, 2010 - 9:56am
tags:
Silenor, Somaxon, insomnia, P&G

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.